Measles vaccination in health care personnel: Mandates, ethics, and patient safety

Vaccine

Volumn 30, Issue 30, 2012, Pages 4407-4408

  Wicker, Sabine ^a   Poland, Gregory A ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEALTH CARE PERSONNEL; HUMAN; MEASLES VACCINATION; MEDICAL ETHICS; PATIENT SAFETY; PRIORITY JOURNAL;

CROSS INFECTION; HEALTH PERSONNEL; HEALTH POLICY; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; MEASLES; MEASLES VACCINE; PATIENT SAFETY; VACCINATION;

EID: 84862012978     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.05.015     Document Type: Editorial

References (26)

1. Mulholland E.K., Griffiths U.K., Biellik R. Measles in the 21st century. New England Journal of Medicine 2012, 366(19):1755-1757.
2. Orenstein W.A., Papania M.J., Wharton M.E. Measles elimination in the United States. Journal of Infectious Diseases 2004, 189(May (Suppl. 1)):S1-S3.
3. European Centre for Disease Prevention and Control Epidemiological update on measles in EU and EEA/EFTA Member States 2011, http://ecdc.europa.eu/en/activities/sciadvice/Lists/ECDC%20Reviews/ECDC_DispForm.aspx?List=512ff74f-77d4-4ad8-b6d6-bf0f23083f30&ID=1086&RootFolder=%2Fen%2Factivities%2Fsciadvice%2FLists%2FECDC%20Reviews [accessed 9.14.11].
4. Simons E., Ferrari M., Fricks J., et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 2012, (April).
5. Ostroff S.M. Measles: going, going, but not gone. Journal of Infectious Diseases 2011, 203(June (11)):1507-1509.
6. Centers for Disease Control and Prevention Immunization of health-care personnel. MMWR 2011, 60(RR-7):1-45.
7. Sepkowitz K.A. Occupationally acquired infections in health care workers. Part I. Annals of Internal Medicine 1996, 125(November (10)):826-834.
8. Steingart K.R., Thomas A.R., Dykewicz C.A., Redd S.C. Transmission of measles virus in healthcare settings during a communitywide outbreak. Infection Control and Hospital Epidemiology 1999, 20(February (2)):115-119.
9. Chen S.Y., Anderson S., Kutty P.K., et al. Health care-associated measles outbreak in the United States after an importation: challenges and economic impact. Journal of Infectious Diseases 2011, 203(June (11)):1517-1525.
10. Weber D.J., Consoli S., Sickbert-Bennett E., Miller M.B., Rutala W.A. Susceptibility to measles, mumps, and rubella in newly hired (2006-2008) healthcare workers born before 1957. Infection Control and Hospital Epidemiology 2010, 31(June (6)):655-657.
11. Ammari L.K., Bell L.M., Hodinka R.L. Secondary measles vaccine failure in healthcare workers exposed to infected patients. Infection Control and Hospital Epidemiology 1993, 14:81-86.
12. Farizo K.M., Stehr-Green P.A., Simpson D.M., Markowitz L.E. Pediatric emergency room visits: a risk factor for acquiring measles. Pediatrics 1991, 87(January (1)):74-79.
13. Rivera M.E., Mason W.H., Ross L.A., Wright H.T. Nosocomial measles infection in a pediatric hospital during a community-wide epidemic. Journal of Pediatrics 1991, 119:183-186.
14. Centers for Disease Control and Prevention Immunization administration requirements for hospital employees for MMR 2012, http://www.cdc.gov/print.do?url=http%3A%2F%2Fwww2a.cdc.gov%2Fnip%2FStateVaccApp%2FstatevaccsApp%2FAdministrationbyVaccine.asp%3FVaccinetmp%3DMMR [accessed 05.03.12].
15. Centers for Disease Control and Prevention Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP) 1998, Report No.: 47/(RR-8).
16. Maltezou H.C., Wicker S., Borg M., et al. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine 2011, 29(September (51)):9557-9562.
17. Heininger U., Bachtiar N.S., Bahri P., et al. The concept of vaccination failure. Vaccine 2012, 30(February (7)):1265-1268.
18. Uzicanin A., Zimmerman L. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature. Journal of Infectious Diseases 2011, 204(July (Suppl. 1)):S133-S148.
19. Willy M.E., Koziol D.E., Fleisher T., et al. Measles immunity in a population of healthcare workers. Infection Control and Hospital Epidemiology 1994, 15(January (1)):12-17.
20. Parker A.A., Staggs W., Dayan G.H., et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. New England Journal of Medicine 2006, 355(August (5)):447-455.
21. Poland G.A., Jacobson R.M. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons. Archives of Internal Medicine 1994, 154:1815-1820.
22. De S.G., Boulianne N., Defay F., et al. Higher risk of measles when the first dose of a two-dose schedule is given at 12-14 versus 15 months of age. Clinical Infectious Diseases 2012, (April).
23. Poland G.A., Jacobson R.M. The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines?. Vaccine 2012, 30(January (2)):103-104.
24. Centers for Disease Control and Prevention Hospital-associated measles outbreak - Pensylvania, March-April 2009. MMWR 2012, 61:30-32.
25. Wicker S., Allwinn R., Gottschalk R., Rabenau H.F. Reliability of medical students' vaccination histories for immunisable diseases. BMC Public Health 2008, 8:121.
26. Jacobson R.M., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Poland G.A. Independence of measles-specific humoral and cellular immune responses to vaccination. Human Immunology 2012, (March).